CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 45 enrolled
Drug / intervention
Prostate Artery Embolizationdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02026908
NCT02026908N/ACompleted
CompareCT.gov

Prostatic Artery Embolization (PAE) for Treatment of Signs and Symptoms of Benign Prostatic Hyperplasia (BPH)

Northwestern University·interventional·Posted Jan 3, 2014·Updated Nov 18, 2024

In Brief

A clinical study evaluating Prostate Artery Embolization for Benign Prostatic Hyperplasia (BPH). Completed, enrolled 45 participants across 1 site.

Detailed Summary

This is an open-labeled, non-randomized feasibility study to evaluate the safety of prostate artery embolization (PAE) for the treatment of lower urinary tract symptoms attributed to benign prostatic hyperplasia (BPH).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBenign Prostatic Hyperplasia (BPH)
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedJan 3, 2014
Enrollment StartJan 1, 2014
Primary CompletionMar 27, 2023
TodayJul 2, 2026
Enrollment to primary: 9.2 yearsPosted 12.5 years ago

Interventions

Prostate Artery Embolizationdevice

Procedure completed in Interventional Radiology includes a pelvic/prostate angiogram and embolization with Embosphere microspheres to slow/block blood flow to the prostate.